A Muhamad Ibrahim

Title: A Muhamad Ibrahim: Innovator in Nephrotoxicity Management

Introduction

A Muhamad Ibrahim is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical science, particularly in the management of nephrotoxicity. His innovative work has led to the development of a unique composition that holds promise for improving health outcomes in mammals.

Latest Patents

A Muhamad Ibrahim holds a patent for "Compositions for management of acute nephrotoxicity." This composition is enriched with bisdemethoxycurcumin, standardized to contain 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin, and 10-50% w/w curcumin. The invention discloses the potential of this composition in managing nephrotoxicity, showcasing its effectiveness in mammals. Additionally, the composition includes an extract standardized to contain not less than 2% w/w thymoquinone and about 0.01%-10% w/w thymohydroquinone.

Career Highlights

A Muhamad Ibrahim is associated with Sami-Sabinsa Group Limited, where he continues to work on innovative solutions in the field of health and wellness. His dedication to research and development has positioned him as a key figure in his organization.

Collaborations

A Muhamad Ibrahim has collaborated with notable colleagues such as Muhammed Majeed and Kalyanam Nagabhushanam. Their combined expertise contributes to the advancement of research and innovation in their respective fields.

Conclusion

A Muhamad Ibrahim's contributions to the management of nephrotoxicity through his patented compositions highlight his role as an innovator in medical science. His work not only reflects his dedication to improving health outcomes but also underscores the importance of collaboration in advancing research.